experspadmin

Comparative Risk of Cardiovascular Events With Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis
Rheumatology

Comparative Risk of Cardiovascular Events With Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis

clinical topic updates
By Leonard H. Calabrese, DO
Non–Tumor Necrosis Factor Biologic Therapies in Rheumatoid Arthritis: The Expanding Evidence Base
Rheumatology

Non–Tumor Necrosis Factor Biologic Therapies in Rheumatoid Arthritis: The Expanding Evidence Base

expert roundtables
By Jeffrey R. Curtis, MD, MS, MPH; Jonathan Kay, MD; Leonard H. Calabrese, DO
Predicting Treatment Response in Patients With Inadequate Responses to Methotrexate
Rheumatology

Predicting Treatment Response in Patients With Inadequate Responses to Methotrexate

expert roundtables
By Jeffrey R. Curtis, MD, MS, MPH; Jonathan Kay, MD; Leonard H. Calabrese, DO
Improving the Daily Lives and Functional Outcomes of Patients With Sickle Cell Disease
Hematology

Improving the Daily Lives and Functional Outcomes of Patients With Sickle Cell Disease

patient care perspectives
By Michael Rutledge DeBaun, MD, MPH
Pain Management and Opioid Analgesics for Sickle Cell Disease
Hematology

Pain Management and Opioid Analgesics for Sickle Cell Disease

patient care perspectives
By Michael Rutledge DeBaun, MD, MPH
Load More